Citations (181)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Daniel L Hertz. (2021) Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships. Expert Opinion on Drug Metabolism & Toxicology 17:2, pages 227-239.
Read now
Read now
Yingmin Nie, Jingjie Yang, Shuai Liu, Ruiqi Sun, Huihui Chen, Nan Long, Rui Jiang & Chunshan Gui. (2020) Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics. Xenobiotica 50:3, pages 297-317.
Read now
Read now
Ruba Al-Abdulla, Laura Perez-Silva, Lorena Abete, Marta R. Romero, Oscar Briz & Jose J. G. Marin. (2019) Unraveling ‘The Cancer Genome Atlas’ information on the role of SLC transporters in anticancer drug uptake. Expert Review of Clinical Pharmacology 12:4, pages 329-341.
Read now
Read now
Ela Cerovska, Katerina Elsnerova, Radka Vaclavikova & Pavel Soucek. (2017) The role of membrane transporters in ovarian cancer chemoresistance and prognosis. Expert Opinion on Drug Metabolism & Toxicology 13:7, pages 741-753.
Read now
Read now
Sylvia Chen, Natalia Sutiman, Clara Zhenxian Zhang, Yingnan Yu, Shirley Lam, Chiea Chuen Khor & Balram Chowbay. (2016) Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review. Drug Metabolism Reviews 48:4, pages 502-540.
Read now
Read now
Candido G Da Silva, Richard J Honeywell, Henk Dekker & Godefridus J Peters. (2015) Physicochemical properties of novel protein kinase inhibitors in relation to their substrate specificity for drug transporters. Expert Opinion on Drug Metabolism & Toxicology 11:5, pages 703-717.
Read now
Read now
Kai Zhan, Juan Yao, Jiujiu Huang, Guangming Zhou, Wenjian Li, Lixin Chen & Mei Hong. (2013) Effect of X-ray irradiation on expression of organic anion transporting polypeptides. International Journal of Radiation Biology 89:10, pages 832-840.
Read now
Read now
Insoo Yoon, Seungyon Han, Young-Hee Choi, Hee-Eun Kang, Hyun-Jong Cho, Jung Sun Kim, Chang-Koo Shim, Suk-Jae Chung, Saeho Chong & Dae-Duk Kim. (2012) Saturable sinusoidal uptake is rate-determining process in hepatic elimination of docetaxel in rats. Xenobiotica 42:11, pages 1110-1119.
Read now
Read now
Lan-Xiang Wu, Cheng-Xian Guo, Qiang Qu, Jing Yu, Wang-Qing Chen, Guo Wang, Lan Fan, Qing Li, Wei Zhang & Hong-Hao Zhou. (2012) Effects of natural products on the function of human organic anion transporting polypeptide 1B1. Xenobiotica 42:4, pages 339-348.
Read now
Read now
Anna Koenen, Heyo K Kroemer, Markus Grube & Henriette E Meyer zu Schwabedissen. (2011) Current understanding of hepatic and intestinal OATP-mediated drug–drug interactions. Expert Review of Clinical Pharmacology 4:6, pages 729-742.
Read now
Read now
Christina Fahrmayr, Martin F. Fromm & Jörg König. (2010) Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects. Drug Metabolism Reviews 42:3, pages 380-401.
Read now
Read now
Raffaele Longo, Mario D'Andrea, Roberta Sarmiento & Giampietro Gasparini. (2010) Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab. Expert Opinion on Investigational Drugs 19:sup1, pages S41-S50.
Read now
Read now
Ichiro Ieiri, Shun Higuchi & Yuichi Sugiyama. (2009) Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Expert Opinion on Drug Metabolism & Toxicology 5:7, pages 703-729.
Read now
Read now
Jürgen Kindla, Martin F Fromm & Jörg König. (2009) In vitro evidence for the role of OATP and OCT uptake transporters in drug–drug interactions. Expert Opinion on Drug Metabolism & Toxicology 5:5, pages 489-500.
Read now
Read now
B. Hagenbuch & C. Gui. (2008) Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38:7-8, pages 778-801.
Read now
Read now
Anne T Nies, Matthias Schwab & Dietrich Keppler. (2008) Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Expert Opinion on Drug Metabolism & Toxicology 4:5, pages 545-568.
Read now
Read now
Annick Seithel, Hartmut Glaeser, Martin F Fromm & Jörg König. (2008) The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members. Expert Opinion on Drug Metabolism & Toxicology 4:1, pages 51-64.
Read now
Read now
Robert O'Connor, Martin Clynes, Paul Dowling, Norma O'Donovan & Lorraine O'Driscoll. (2007) Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 805-817.
Read now
Read now
Dhananjay Pal & Ashim K. Mitra. (2006) CYP3A4 and MDR Mediated Interactions in Drug Therapy. Clinical Research and Regulatory Affairs 23:3-4, pages 125-163.
Read now
Read now
Nicola F Smith, William D Figg & Alex Sparreboom. (2005) Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Expert Opinion on Drug Metabolism & Toxicology 1:3, pages 429-445.
Read now
Read now
Articles from other publishers (161)
Katsuhiko Nara, Takehito Yamamoto, Hiroharu Yamashita, Koichi Yagi, Tappei Takada, Yasuyuki Seto & Hiroshi Suzuki. (2023) Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study. BMC Cancer 23:1.
Crossref
Crossref
Maitane Asensio, Elisa Herraez, Rocio I.R. Macias, Elisa Lozano, Luis Muñoz-Bellvís, Laura Sanchez-Vicente, Ana Morente-Carrasco, Jose J.G. Marin & Oscar Briz. (2023) Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma. Biochemical Pharmacology 214, pages 115681.
Crossref
Crossref
Yang Li, Thomas Drabison, Mahesh Nepal, Richard H. Ho, Alix F. Leblanc, Alice A. Gibson, Yan Jin, Wenjian Yang, Kevin M. Huang, Muhammad Erfan Uddin, Mingqing Chen, Duncan F. DiGiacomo, Xihui Chen, Sobia Razzaq, Jeffrey R. Tonniges, Dana M. McTigue, Alice S. Mims, Maryam B. Lustberg, Yijia Wang, Amanda B. Hummon, William E. Evans, Sharyn D. Baker, Guido Cavaletti, Alex Sparreboom & Shuiying Hu. (2023) Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy. JCI Insight 8:14.
Crossref
Crossref
Pooja Dhakne, Megha Pillai, Sonam Mishra, Bappaditya Chatterjee, Rakesh K. Tekade & Pinaki Sengupta. (2023) Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188906.
Crossref
Crossref
Ines Klein, Jörg Isensee, Martin H. J. Wiesen, Thomas Imhof, Meike K. Wassermann, Carsten Müller, Tim Hucho, Manuel Koch & Helmar C. Lehmann. (2023) Glycyrrhizic Acid Prevents Paclitaxel-Induced Neuropathy via Inhibition of OATP-Mediated Neuronal Uptake. Cells 12:9, pages 1249.
Crossref
Crossref
Solène Marie, Kayla L. Frost, Raymond K. Hau, Lucy Martinez-Guerrero, Jailyn M. Izu, Cassandra M. Myers, Stephen H. Wright & Nathan J. Cherrington. (2023) Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients. Acta Pharmaceutica Sinica B 13:1, pages 1-28.
Crossref
Crossref
Arun Kumar Tonduru, Santosh Kumar Adla, Kristiina M. Huttunen, Thales Kronenberger & Antti Poso. (2022) Comparative Modelling of Organic Anion Transporting Polypeptides: Structural Insights and Comparison of Binding Modes. Molecules 27:23, pages 8531.
Crossref
Crossref
Angelo E. Andres, Andres Mariano, Digamber Rane & Blake R. Peterson. (2022) Quantification of Engagement of Microtubules by Small Molecules in Living Cells by Flow Cytometry. ACS Bio & Med Chem Au 2:5, pages 529-537.
Crossref
Crossref
Anne T. Nies, Elke Schaeffeler & Matthias Schwab. (2022) Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. Pharmacology & Therapeutics 238, pages 108268.
Crossref
Crossref
Shanshan Jiang, Yunfei Luo, Zhan Zhan, Zhimin Tang, Junrong Zou, Ying Ying, Hui Lin, Deqiang Huang & Lingyu Luo. (2022) AMP-activated protein kinase re-sensitizes A549 to paclitaxel via up-regulating solute carrier organic anion transporter family member 1B3 expression. Cellular Signalling 91, pages 110215.
Crossref
Crossref
Young-gon Kim, Hobin Sung, Ho Seob Shin, Man Jin Kim, Jee-Soo Lee, Sung-Sup Park & Moon-Woo Seong. (2021) Intronic LINE-1 insertion in SLCO1B3 as a highly prevalent cause of rotor syndrome in East Asian population. Journal of Human Genetics 67:2, pages 71-77.
Crossref
Crossref
Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino, Licia Pensabene, Pierfrancesco Tassone & Pierosandro Tagliaferri. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
657
697
.
Zahra Talebi, Alex Sparreboom & Susan I. Colace. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
63
94
.
Michael Haimerl, Kirsten Utpatel, Andrea Götz, Florian Zeman, Claudia Fellner, Dominik Nickel, Lukas Luerken, Frank Brennfleck, Christian Stroszczynski, Alexander Scheiter & Niklas Verloh. (2021) Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade. Scientific Reports 11:1.
Crossref
Crossref
Jianfei Chen, Guoying Hua, Deping Han, Xiaotong Zheng, Xianggui Dong, Shuxiang Wang, Junjiang Long, Zhonghua Zheng, Ailing Wang, Jiankui Wang, Xiaotong Wang & Xuemei Deng. (2021) An EAV-HP insertion in the promoter region of SLCO1B3 has pleiotropic effects on chicken liver metabolism based on the transcriptome and proteome analysis. Scientific Reports 11:1.
Crossref
Crossref
Tore B. Stage, Shuiying Hu, Alex Sparreboom & Deanna L. Kroetz. (2020) Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy. Clinical and Translational Science 14:2, pages 460-467.
Crossref
Crossref
Maria D. Auxtero, Susana Chalante, Mário R. Abade, Rui Jorge & Ana I. Fernandes. (2021) Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction. Pharmaceutics 13:1, pages 124.
Crossref
Crossref
Lisanne Mout, Jan M. Moll, Mingqing Chen, Eleonora S. de Morrée, Corrina M. A. de Ridder, Alice Gibson, Debra Stuurman, Ashraf Aghai, Sigrun Erkens-Schulze, Ron H. J. Mathijssen, Alex Sparreboom, Ronald de Wit, Martijn P. Lolkema & Wytske M. van Weerden. (2020) Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer. British Journal of Cancer 123:12, pages 1715-1719.
Crossref
Crossref
Tore B. Stage, Christina Mortensen, Sehbar Khalaf, Vivien Steffensen, Helen S. Hammer, Chenling Xiong, Flemming Nielsen, Oliver Poetz, Åsa Fex Svenningsen, Cristina Rodriguez‐Antona & Deanna L. Kroetz. (2020) P‐Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. Clinical Pharmacology & Therapeutics 108:3, pages 671-680.
Crossref
Crossref
Supratim Choudhuri & Curtis D. Klaassen. (2020) Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms. Toxicology and Applied Pharmacology 399, pages 115039.
Crossref
Crossref
Weihua Ren, Chenxi Zhou, Yedong Liu, Keli Su, Li Jia, Luan Chen, Mo Li, Jingsong Ma, Wei Zhou, Suli Zhang, Di Zhang, Zhiliang Cong, Xuecai Niu, Shengui Zhang, Lu Shen, Cong Huai, Xiaofang Sun, Guorong Li, Shengying Qin & Liang Guo. (2019) Genetic associations of docetaxel‐based chemotherapy‐induced myelosuppression in Chinese Han population. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 354-364.
Crossref
Crossref
Simon Nicolussi, Jürgen Drewe, Veronika Butterweck & Henriette E. Meyer zu Schwabedissen. (2020) Clinical relevance of St. John's wort drug interactions revisited. British Journal of Pharmacology 177:6, pages 1212-1226.
Crossref
Crossref
Eiman Y. Ibrahim & Barbara E. Ehrlich. (2020) Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. Critical Reviews in Oncology/Hematology 145, pages 102831.
Crossref
Crossref
Jason T. Anderson, Kevin M. Huang, Maryam B. Lustberg, Alex Sparreboom & Shuiying Hu. 2022. Targets of Cancer Diagnosis and Treatment. Targets of Cancer Diagnosis and Treatment
177
215
.
Ruipu Sun, Ying Ying, Zhimin Tang, Ting Liu, Fuli Shi, Huixia Li, Taichen Guo, Shibo Huang & Ren Lai. (2019) The Emerging Role of the SLCO1B3 Protein in Cancer Resistance. Protein & Peptide Letters 27:1, pages 17-29.
Crossref
Crossref
Zhiqi Wang, Nan Zhang, Chaoyang Chen, Shuqing Chen, Junyu Xu, Ying Zhou, Xia Zhao & Yimin Cui. (2019) Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients. Current Drug Metabolism 20:7, pages 592-600.
Crossref
Crossref
Rachael R. Schulte & Richard H. Ho. (2019) Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology. Molecular Pharmacology 95:5, pages 490-506.
Crossref
Crossref
Tristan M. Sissung, Arun Rajan, Gideon M. Blumenthal, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Giuseppe Giaccone & William D. Figg. (2019) Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer. PLOS ONE 14:2, pages e0212097.
Crossref
Crossref
Y. W. Francis Lam. 2019. Pharmacogenomics. Pharmacogenomics
1
53
.
Fayou Yang, Linlin Liu, Lin Chen, Mingyi Liu, Fanglan Liu, Yuqing Xiong, Xiao Hu & Chunhua Xia. (2018) OATP1B3 (699G>A) and CYP2C9*2, *3 significantly influenced the transport and metabolism of glibenclamide and glipizide. Scientific Reports 8:1.
Crossref
Crossref
Rodrigo Cristofoletti, Malcolm Rowland, Lawrence J. Lesko, Henning Blume, Amin Rostami-Hodjegan & Jennifer B. Dressman. (2018) Past, Present, and Future of Bioequivalence: Improving Assessment and Extrapolation of Therapeutic Equivalence for Oral Drug Products. Journal of Pharmaceutical Sciences 107:10, pages 2519-2530.
Crossref
Crossref
Hironao Okubo, Hitoshi Ando, Yushi Sorin, Eisuke Nakadera, Hiroo Fukada, Junichi Morishige, Akihisa Miyazaki & Kenichi Ikejima. (2018) Gadoxetic acid–enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C. PLOS ONE 13:4, pages e0196747.
Crossref
Crossref
Alix F. Leblanc, Jason A. Sprowl, Paola Alberti, Alessia Chiorazzi, W. David Arnold, Alice A. Gibson, Kristen W. Hong, Marissa S. Pioso, Mingqing Chen, Kevin M. Huang, Vamsi Chodisetty, Olivia Costa, Tatiana Florea, Peter de Bruijn, Ron H. Mathijssen, Raquel E. Reinbolt, Maryam B. Lustberg, Lara E. Sucheston-Campbell, Guido Cavaletti, Alex Sparreboom & Shuiying Hu. (2018) OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. Journal of Clinical Investigation 128:2, pages 816-825.
Crossref
Crossref
Tore B. Stage, Troels K. Bergmann & Deanna L. Kroetz. (2017) Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review. Clinical Pharmacokinetics 57:1, pages 7-19.
Crossref
Crossref
Xitong Su, Lei Wu, Mingming Hu, Wenxiang Dong, Meng Xu & Peng Zhang. (2017) Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomedicine & Pharmacotherapy 95, pages 670-678.
Crossref
Crossref
Michael Murray & Fanfan Zhou. (2017) Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease. British Journal of Pharmacology 174:13, pages 1908-1924.
Crossref
Crossref
Fanfan Zhou, Ling Zhu, Ke Wang & Michael Murray. (2017) Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition. Advanced Drug Delivery Reviews 116, pages 21-36.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
77
138
.
Chao Zhou, Yang Rong, Teruaki Konishi, Zhaojian Xiang, Fang Zihui & Mei Hong. (2017) Effect of Carbon-Ion Radiation on Drug Transporters Organic Anion Transporting Polypeptides in Breast Cancer Cells. Radiation Research 187:6, pages 689-700.
Crossref
Crossref
Hannah H. Lee, Brenda F. Leake, Richard B. Kim & Richard H. Ho. (2017) Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance. Molecular Pharmacology 91:1, pages 14-24.
Crossref
Crossref
Rodrigo Cristofoletti & Jennifer B. Dressman. (2016) Bridging the Gap Between In Vitro Dissolution and the Time Course of Ibuprofen-Mediating Pain Relief. Journal of Pharmaceutical Sciences 105:12, pages 3658-3667.
Crossref
Crossref
Takaaki Shimakata, Shingo Kamoshida, Jumpei Kawamura, Naoki Ogane, Yoichi Kameda, Emmy Yanagita, Tomoo Itoh, Risa Takeda, Ayano Naka, Kuniko Sakamaki, Yurie Hayashi & Sadahito Kuwao. (2016) Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer. Histopathology 69:5, pages 812-821.
Crossref
Crossref
Xiaolin Sun, Junxiu Li, Chaorui Guo, Han Xing, Jie Xu, Yanli Wen, Zhixia Qiu, Qiuyang Zhang, Yi Zheng, Xijing Chen & Di Zhao. (2016) Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s. Drug Metabolism and Pharmacokinetics 31:4, pages 269-275.
Crossref
Crossref
Hyung Soon Park, Sun Min Lim, Ho Jung Shin, Arthur Cho, Jae-Gook Shin, Min Goo Lee, Hye Ryun Kim, Joo Hang Kim & Byoung Chul Cho. (2016) Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy. Pharmacogenetics and Genomics 26:3, pages 116-125.
Crossref
Crossref
Sandrina Lambrechts, Diether Lambrechts, Evelyn Despierre, Els Van Nieuwenhuysen, Dominiek Smeets, Philip R Debruyne, Vincent Renard, Philippe Vroman, Daisy Luyten, Patrick Neven, Frédéric Amant, Karin Leunen & Ignace Vergote. (2015) Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC Pharmacology and Toxicology 16:1.
Crossref
Crossref
Aurélie Dumont, Diane Pannier, Agnès Ducoulombier, Emmanuelle Tresch, Jinying Chen, Andrew Kramar, Françoise Révillion, Jean-Philippe Peyrat & Jacques Bonneterre. (2015) ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors. SpringerPlus 4:1.
Crossref
Crossref
Francesca De Iuliis, Gerardo Salerno, Ludovica Taglieri & Susanna Scarpa. (2015) Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review. Cancer Chemotherapy and Pharmacology 76:4, pages 679-690.
Crossref
Crossref
Céline Callens, Marc Debled, Marc Delord, Isabelle Turbiez-Stalain, Corinne Veyret, Ivan Bièche & Etienne Brain. (2015) High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial. Breast Cancer Research and Treatment 153:2, pages 383-389.
Crossref
Crossref
Rui Peng, Hong Zhang, Ying Zhang & Dan-yun Wei. (2015) RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines. Cancer Chemotherapy and Pharmacology 76:3, pages 657-657.
Crossref
Crossref
Jung Ran Choi, Jeong-Oh Kim, Dae Ryong Kang, Jung-Young Shin, Xiang Hua Zhang, Ji Eun Oh, Ji-Young Park, Kyoung-Ah Kim & Jin-Hyoung Kang. (2014) Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy. Cancer Research and Treatment 47:3, pages 509-517.
Crossref
Crossref
Annemieke JM Nieuweboer, Marcel Smid, Anne-Joy M de Graan, Samira Elbouazzaoui, Peter de Bruijn, John W Martens, Ron HJ Mathijssen & Ron HN van Schaik. (2015) Predicting paclitaxel-induced neutropenia using the DMET platform. Pharmacogenomics 16:11, pages 1231-1241.
Crossref
Crossref
Nilay Thakkar, A. Craig Lockhart & Wooin Lee. (2015) Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy. The AAPS Journal 17:3, pages 535-545.
Crossref
Crossref
Agnes Nagy, Renata Szalai, Lili Magyari, Judit Bene, Kalman Toth & Bela Melegh. (2015) Extreme differences in SLCO1B3 functional polymorphisms in Roma and Hungarian populations. Environmental Toxicology and Pharmacology 39:3, pages 1246-1251.
Crossref
Crossref
Hannah H. Lee, Brenda F. Leake, Wendy Teft, Rommel G. Tirona, Richard B. Kim & Richard H. Ho. (2015) Contribution of Hepatic Organic Anion-Transporting Polypeptides to Docetaxel Uptake and Clearance. Molecular Cancer Therapeutics 14:4, pages 994-1003.
Crossref
Crossref
Venkata V.V.R. Marada, Saskia Flörl, Annett Kühne, Gerhard Burckhardt & Yohannes Hagos. (2015) Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds. European Journal of Medicinal Chemistry 92, pages 723-731.
Crossref
Crossref
Abdulrahman K. Al-Asmari, Zabih Ullah, Fahad Al-Sabaan, Mohammad Tariq, Ahmed Al-Eid & Saud F. Al-Omani. (2014) Effect of vitamin D on bioavailability and lipid lowering efficacy of simvastatin. European Journal of Drug Metabolism and Pharmacokinetics 40:1, pages 87-94.
Crossref
Crossref
Rongrong Jiang, Jiajia Dong, Xiuxue Li, Feifei Du, Weiwei Jia, Fang Xu, Fengqing Wang, Junling Yang, Wei Niu & Chuan Li. (2015) Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3. British Journal of Pharmacology 172:4, pages 1059-1073.
Crossref
Crossref
Dilek Iusuf, Jeroen J.M.A. Hendrikx, Anita van Esch, Evita van de Steeg, Els Wagenaar, Hilde Rosing, Jos H. Beijnen & Alfred H. Schinkel. (2015)
Human OATP1B1, OATP1B3 and OATP1A2 can mediate the
in vivo
uptake and clearance of docetaxel
. International Journal of Cancer 136:1, pages 225-233.
Crossref
Crossref
Tristan M. Sissung, Douglas K. Price, Marzia Del Re, Ariel M. Ley, Elisa Giovannetti, William D. Figg & Romano Danesi. (2014) Genetic variation: effect on prostate cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 446-456.
Crossref
Crossref
Serena Marchetti, Dick Pluim, Jos H. Beijnen, Roberto Mazzanti, Olaf van Tellingen & Jan H. M. Schellens. (2014) “Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183”. Investigational New Drugs 32:6, pages 1083-1095.
Crossref
Crossref
Rosie A. Johnston, Tristan Rawling, Ting Chan, Fanfan Zhou & Michael Murray. (2014) Selective Inhibition of Human Solute Carrier Transporters by Multikinase Inhibitors. Drug Metabolism and Disposition 42:11, pages 1851-1857.
Crossref
Crossref
Takeo Nakanishi & Ikumi Tamai. (2014) Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers. Biopharmaceutics & Drug Disposition 35:8, pages 463-484.
Crossref
Crossref
A Yamada, K Maeda, K Kiyotani, T Mushiroda, Y Nakamura & Y Sugiyama. (2014) Kinetic Interpretation of the Importance of OATP1B3 and MRP2 in Docetaxel‐Induced Hematopoietic Toxicity. CPT: Pharmacometrics & Systems Pharmacology 3:7, pages 1-10.
Crossref
Crossref
Annemieke J.M. Nieuweboer, Shuiying Hu, Chunshan Gui, Bruno Hagenbuch, Inge M. Ghobadi Moghaddam-Helmantel, Alice A. Gibson, Peter de Bruijn, Ron H.J. Mathijssen & Alex Sparreboom. (2014) Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel. Cancer Research 74:11, pages 3137-3145.
Crossref
Crossref
Hideki IshimaruKazuaki NakashimaTakayuki SakugawaAyami SakamotoYohjiro MatsuokaKazuto AshizawaMasataka Uetani. (2014) Local Recurrence After Chemoembolization of Hepatocellular Carcinoma: Uptake of Gadoxetic Acid as a New Prognostic Factor. American Journal of Roentgenology 202:4, pages 744-751.
Crossref
Crossref
Jason A. Sprowl & Alex Sparreboom. (2014) Uptake Carriers and Oncology Drug Safety. Drug Metabolism and Disposition 42:4, pages 611-622.
Crossref
Crossref
Henriette E. Meyer zu Schwabedissen, Robert Begunk, Janine Hussner, B. Ole Juhnke, Daniel Gliesche, Kerstin Böttcher, Katrin Sternberg, Klaus-Peter Schmitz & Heyo K. Kroemer. (2014) Cell-Specific Expression of Uptake Transporters—A Potential Approach for Cardiovascular Drug Delivery Devices. Molecular Pharmaceutics 11:3, pages 665-672.
Crossref
Crossref
Yoshihide Kimura, Shinya Sato, Eiichi Hitomi, Makoto Ohyama, Kazunori Adachi, Yusuke Inagaki, Yoshihiro Yamakawa, Atsuyuki Hirano, Hiroki Kawai, Kenji Tsuchida, Kyouji Senoo, Kohei Katsumi & Takashi Joh. (2014) Coexpression of organic anion-transporting polypeptides 1B3 and multidrug-resistant proteins 2 increases the enhancement effect of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on hepatocellular carcinoma in magnetic resonance imaging. Hepatology Research 44:3, pages 327-337.
Crossref
Crossref
Henriette E. Meyer zu Schwabedissen, Kerstin Boettcher, Tobias Steiner, Ute I. Schwarz, Markus Keiser, Heyo K. Kroemer & Werner Siegmund. (2014) OATP1B3 Is Expressed in Pancreatic β-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide. Diabetes 63:2, pages 775-784.
Crossref
Crossref
Sin-Chi Chew, Joanne Lim, Onkar Singh, Xiangai Chen, Eng-Huat Tan, Edmund-JD Lee & Balram Chowbay. (2013) Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients. European Journal of Clinical Pharmacology 70:2, pages 155-166.
Crossref
Crossref
Qing Li & Yan Shu. (2014) Role of solute carriers in response to anticancer drugs. Molecular and Cellular Therapies 2:1, pages 15.
Crossref
Crossref
Richard H. Ho & Richard B. Kim. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
401
442
.
Anne-Joy M. de Graan, Laure Elens, Marcel Smid, John W. Martens, Alex Sparreboom, Annemieke J.M. Nieuweboer, Lena E. Friberg, Samira Elbouazzaoui, Erik A.C. Wiemer, Bronno van der Holt, Jaap Verweij, Ron H.N. van Schaik & Ron H.J. Mathijssen. (2013) A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform. Clinical Cancer Research 19:18, pages 5210-5217.
Crossref
Crossref
Amanda Hays, Udayan Apte & Bruno Hagenbuch. (2013) Organic Anion Transporting Polypeptides Expressed in Pancreatic Cancer May Serve As Potential Diagnostic Markers and Therapeutic Targets for Early Stage Adenocarcinomas. Pharmaceutical Research 30:9, pages 2260-2269.
Crossref
Crossref
Cynthia S. Lancaster, Jason A. Sprowl, Aisha L. Walker, Shuiying Hu, Alice A. Gibson & Alex Sparreboom. (2013) Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics. Molecular Cancer Therapeutics 12:8, pages 1537-1544.
Crossref
Crossref
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
Daniel L Hertz. (2013) Germline pharmacogenetics of paclitaxel for cancer treatment. Pharmacogenomics 14:9, pages 1065-1084.
Crossref
Crossref
Zainab AwadaSyed HaiderArafat TfayliAli BazarbachiNagi S. El-SaghirZiad SalemAli ShamseddineAli TaherNathalie Khoueiry Zgheib. (2013) Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast Cancer Patients: Paving the Way for OMICs in Low and Middle Income Countries. OMICS: A Journal of Integrative Biology 17:7, pages 353-367.
Crossref
Crossref
Kathleen Köck, Ying Xie, Roy L. Hawke, Nicholas H. Oberlies & Kim L. R. Brouwer. (2013) Interaction of Silymarin Flavonolignans with Organic Anion-Transporting Polypeptides. Drug Metabolism and Disposition 41:5, pages 958-965.
Crossref
Crossref
Anassuya Ramachandran, Guy Betts, Sara Bhana, Gemma Helme, Christopher Blick, Carla Moller-Levet, Emma Saunders, Helen Valentine, Stuart Pepper, Crispin J. Miller, Francesca Buffa, Adrian L. Harris & Catharine M.L. West. (2013) An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. European Journal of Cancer 49:7, pages 1741-1751.
Crossref
Crossref
Stefanie D Krens, Howard L McLeod & Daniel L Hertz. (2013) Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy. Pharmacogenomics 14:5, pages 555-574.
Crossref
Crossref
Evita van de Steeg, Anita van Esch, Els Wagenaar, Kathryn E. Kenworthy & Alfred H. Schinkel. (2013) Influence of Human OATP1B1, OATP1B3, and OATP1A2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice. Clinical Cancer Research 19:4, pages 821-832.
Crossref
Crossref
Naoki OGANE, Masanori YASUDA, Yoichi KAMEDA, Tomoyuki YOKOSE, Hisamori KATO, Ayumi ITOH, Satoshi NISHINO, Yumi HASHIMOTO & Shingo KAMOSHIDA. (2013) Prognostic value of organic anion transporting polypeptide 1B3 and copper transporter 1 expression in endometrial cancer patients treated with paclitaxel and carboplatin. Biomedical Research 34:3, pages 143-151.
Crossref
Crossref
Inna Y. Gong & Richard B. Kim. (2013) Impact of Genetic Variation in OATP Transporters to Drug Disposition and Response. Drug Metabolism and Pharmacokinetics 28:1, pages 4-18.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
353
454
.
Jasbani HS Dayal, Clare L Cole, Celine Pourreyron, Stephen A Watt, Yok Zuan Lim, Julio C Salas-Alanis, Dedee F Murrell, John A McGrath, Bruno Stieger, Colin Jahoda, Irene M Leigh & Andrew P South. (2013) Type VII collagen regulates tumour expression of organic anion transporting polypeptide OATP1B3, promotes front to rear polarity and increases structural organisation in 3D spheroid cultures of recessive dystrophic epidermolysis bullosa tumour keratinocytes. Journal of Cell Science.
Crossref
Crossref
Lionel D. Lewis, Antonius A. Miller, Kouros Owzar, Robert R. Bies, Svetlana Markova, Chen Jiang, Deanna L. Kroetz, Merrill J. Egorin, Howard L. McLeod & Mark J. Ratain. (2013) The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia. Pharmacogenetics and Genomics 23:1, pages 29-33.
Crossref
Crossref
Y.W. Francis Lam & Larisa H. Cavallari. 2013. Pharmacogenomics. Pharmacogenomics
1
44
.
Rafid Salim Jabir, Rakesh Naidu, Muhammad Azrif Bin Ahmad Annuar, Gwo Fuang Ho, Murali Munisamy & Johnson Stanslas. (2012) Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity. Pharmacogenomics 13:16, pages 1979-1988.
Crossref
Crossref
Paul Berveiller, Cécile Vinot, Olivier Mir, Sophie Broutin, Alain Deroussent, Atmane Seck, Sandra Camps, Angelo Paci, Sophie Gil & Jean-Marc Tréluyer. (2012) Comparative transplacental transfer of taxanes using the human perfused cotyledon placental model. American Journal of Obstetrics and Gynecology 207:6, pages 514.e1-514.e7.
Crossref
Crossref
Martin N. Fransson, Jan Brugård, Peter Aronsson & Henrik Gréen. (2012) Semi-physiologically based pharmacokinetic modeling of paclitaxel metabolism and in silico-based study of the dynamic sensitivities in pathway kinetics. European Journal of Pharmaceutical Sciences 47:4, pages 759-767.
Crossref
Crossref
Joo Hyun Lee, Areum Lee, Ju‐Hee Oh & Young‐Joo Lee. (2012) Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin‐induced diabetic rats. Biopharmaceutics & Drug Disposition 33:8, pages 474-486.
Crossref
Crossref
Anett Engel, Stefan Oswald, Werner Siegmund & Markus Keiser. (2012) Pharmaceutical Excipients Influence the Function of Human Uptake Transporting Proteins. Molecular Pharmaceutics 9:9, pages 2577-2581.
Crossref
Crossref
Maciej J. Zamek-Gliszczynski, David W. Bedwell, Jing Q. Bao & J. William Higgins. (2012) Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Using Loperamide, Paclitaxel, Sulfasalazine, and Carboxydichlorofluorescein Pharmacokinetics. Drug Metabolism and Disposition 40:9, pages 1825-1833.
Crossref
Crossref
Anne-Joy M. de Graan, Cynthia S. Lancaster, Amanda Obaidat, Bruno Hagenbuch, Laure Elens, Lena E. Friberg, Peter de Bruijn, Shuiying Hu, Alice A. Gibson, Gitte H. Bruun, Thomas J. Corydon, Torben S. Mikkelsen, Aisha L. Walker, Guoqing Du, Walter J. Loos, Ron H. N. van Schaik, Sharyn D. Baker, Ron H. J. Mathijssen & Alex Sparreboom. (2012) Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel. Clinical Cancer Research 18:16, pages 4433-4440.
Crossref
Crossref
Uchenna O. Njiaju, Eric R. Gamazon, Lidija K. Gorsic, Shannon M. Delaney, Heather E. Wheeler, Hae Kyung Im & M. Eileen Dolan. (2012) Whole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel. Pharmacogenetics and Genomics 22:7, pages 498-507.
Crossref
Crossref
Henriette E. Meyer zu Schwabedissen, Markus Grube & Heyo K. Kroemer. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy
101
148
.
Sin Chi Chew, Edwin Sandanaraj, Onkar Singh, Xiangai Chen, Eng Huat Tan, Wan Teck Lim, Edmund J. D. Lee & Balram Chowbay. (2012) Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients. British Journal of Clinical Pharmacology 73:4, pages 606-618.
Crossref
Crossref
Megan Roth, Amanda Obaidat & Bruno Hagenbuch. (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. British Journal of Pharmacology 165:5, pages 1260-1287.
Crossref
Crossref
M.K. DeGorterC.Q. Xia, J.J. Yang & R.B. Kim. (2012) Drug Transporters in Drug Efficacy and Toxicity. Annual Review of Pharmacology and Toxicology 52:1, pages 249-273.
Crossref
Crossref
Amanda ObaidatMegan RothBruno Hagenbuch. (2012) The Expression and Function of Organic Anion Transporting Polypeptides in Normal Tissues and in Cancer. Annual Review of Pharmacology and Toxicology 52:1, pages 135-151.
Crossref
Crossref
Dilek Iusuf, Evita van de Steeg & Alfred H. Schinkel. (2012) Functions of OATP1A and 1B transporters in vivo: insights from mouse models. Trends in Pharmacological Sciences 33:2, pages 100-108.
Crossref
Crossref
Jason A. Sprowl, Torben S. Mikkelsen, Hugh Giovinazzo & Alex Sparreboom. (2012) Contribution of tumoral and host solute carriers to clinical drug response. Drug Resistance Updates 15:1-2, pages 5-20.
Crossref
Crossref
Takeo Nakanishi & Ikumi Tamai. (2012) Genetic Polymorphisms of OATP Transporters and Their Impact on Intestinal Absorption and Hepatic Disposition of Drugs. Drug Metabolism and Pharmacokinetics 27:1, pages 106-121.
Crossref
Crossref
Chung-Pu Wu, Chia-Hung Hsieh & Yu-Shan Wu. (2011) The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy. Molecular Pharmaceutics 8:6, pages 1996-2011.
Crossref
Crossref
Megan Roth, Juan J. Araya, Barbara N. Timmermann & Bruno Hagenbuch. (2011)
Isolation of Modulators of the Liver-Specific Organic Anion-Transporting Polypeptides (OATPs) 1B1 and 1B3 from
Rollinia emarginata
Schlecht (Annonaceae)
. Journal of Pharmacology and Experimental Therapeutics 339:2, pages 624-632.
Crossref
Crossref
Mitchell E. Taub, Kirsten Mease, Rucha S. Sane, Cory A. Watson, Liangfu Chen, Harma Ellens, Brad Hirakawa, Eric L. Reyner, Marton Jani & Caroline A. Lee. (2011) Digoxin Is Not a Substrate for Organic Anion-Transporting Polypeptide Transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but Is a Substrate for a Sodium-Dependent Transporter Expressed in HEK293 Cells. Drug Metabolism and Disposition 39:11, pages 2093-2102.
Crossref
Crossref
Shigeki Sekine, Reiko Ogawa, Hidenori Ojima & Yae Kanai. (2011) Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. Cancer Science 102:9, pages 1742-1747.
Crossref
Crossref
Martin Svoboda, Katrin Wlcek, Barbara Taferner, Steffen Hering, Bruno Stieger, Dan Tong, Robert Zeillinger, Theresia Thalhammer & Walter Jäger. (2011) Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: Relevance for paclitaxel transport. Biomedicine & Pharmacotherapy 65:6, pages 417-426.
Crossref
Crossref
Takeo Nakanishi & Ikumi Tamai. (2011) Solute Carrier Transporters as Targets for Drug Delivery and Pharmacological Intervention for Chemotherapy. Journal of Pharmaceutical Sciences 100:9, pages 3731-3750.
Crossref
Crossref
Takashi Sekine & Hiroyuki Kusuhara. 2011. Oral Bioavailability. Oral Bioavailability
309
327
.
Robert Tell, Q. Tian Wang, Adam Blunier & Richard V. Benya. (2011) Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation. Clinical Epigenetics 2:2, pages 331-338.
Crossref
Crossref
Fabian MüllerMartin F Fromm. (2011) Transporter-mediated drug–drug interactions. Pharmacogenomics 12:7, pages 1017-1037.
Crossref
Crossref
Heather Pressler, Tristan M. Sissung, David Venzon, Douglas K. Price & William D. Figg. (2011) Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression. PLoS ONE 6:5, pages e20372.
Crossref
Crossref
S Leskelä, C Jara, L J Leandro-García, A Martínez, J García-Donas, S Hernando, A Hurtado, J C C Vicario, C Montero-Conde, I Landa, E López-Jiménez, A Cascón, R L Milne, M Robledo & C Rodríguez-Antona. (2010) Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. The Pharmacogenomics Journal 11:2, pages 121-129.
Crossref
Crossref
Mikko Niemi, Marja K. Pasanen & Pertti J. Neuvonen. (2011) Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake. Pharmacological Reviews 63:1, pages 157-181.
Crossref
Crossref
Evita van de Steeg, Anita van Esch, Els Wagenaar, Cornelia M.M. van der Kruijssen, Olaf van Tellingen, Kathryn E. Kenworthy & Alfred H. Schinkel. (2011)
High Impact of Oatp1a/1b Transporters on
In Vivo
Disposition of the Hydrophobic Anticancer Drug Paclitaxel
. Clinical Cancer Research 17:2, pages 294-301.
Crossref
Crossref
U. Olszewski-HamiltonM. SvobodaT. ThalhammerV. Buxhofer-AuschK. GeisslerG. Hamilton. (2011) Organic Anion Transporting Polypeptide 5A1 (OATP5A1) in Small Cell Lung Cancer (SCLC) Cells: Possible Involvement in Chemoresistance to Satraplatin. Biomarkers in Cancer 3, pages BIC.S7151.
Crossref
Crossref
Alli Laitinen & Mikko Niemi. (2011) Frequencies of Single-Nucleotide Polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 Genes in a Finnish Population. Basic & Clinical Pharmacology & Toxicology 108:1, pages 9-13.
Crossref
Crossref
Jörg König. 2011. Drug Transporters. Drug Transporters
1
28
.
Ryan M. FrankeMichael A. CarducciMichelle A. RudekSharyn D. BakerAlex Sparreboom. (2010) Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer. Journal of Clinical Oncology 28:30, pages 4562-4567.
Crossref
Crossref
Huadong Sun & K. Sandy Pang. (2010) Physiological Modeling to Understand the Impact of Enzymes and Transporters on Drug and Metabolite Data and Bioavailability Estimates. Pharmaceutical Research 27:7, pages 1237-1254.
Crossref
Crossref
Cristina Rodríguez-Antona. (2010) Pharmacogenomics of paclitaxel. Pharmacogenomics 11:5, pages 621-623.
Crossref
Crossref
Chunshan Gui & Bruno Hagenbuch. (2010) Cloning/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP/SLCO members. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 151:3, pages 393-399.
Crossref
Crossref
Sayaka Ichihara, Ryota Kikuchi, Hiroyuki Kusuhara, Satoki Imai, Kazuya Maeda & Yuichi Sugiyama. (2010) DNA Methylation Profiles of Organic Anion Transporting Polypeptide 1B3 in Cancer Cell Lines. Pharmaceutical Research 27:3, pages 510-516.
Crossref
Crossref
Tristan M. Sissung, Caitlin E. Baum, C. Tyler Kirkland, Rui Gao, Erin R. Gardner & William D. Figg. (2009) Pharmacogenetics of Membrane Transporters: An Update on Current Approaches. Molecular Biotechnology 44:2, pages 152-167.
Crossref
Crossref
Tadatoshi Tanino, Akihiro Nawa, Mao Nakao, Manabu Noda, Sawako Fujiwara & Masahiro Iwaki. (2009) Organic anion transporting polypeptide 2-mediated uptake of paclitaxel and 2′-ethylcarbonate-linked paclitaxel in freshly isolated rat hepatocytes. Journal of Pharmacy and Pharmacology 61:8, pages 1029-1035.
Crossref
Crossref
Masashi Kawami, Ryoko Yumoto, Junya Nagai, Varaporn Buraphacheep Junyaprasert, Noppamas Soonthornchareonnon, Denpong Patanasethanont, Bung-orn Sripanidkulchai & Mikihisa Takano. (2010) Effect of Thai Plant Extracts on P-glycoprotein Function and Viability in Paclitaxel-Resistant HepG2 Cells. Drug Metabolism and Pharmacokinetics 25:2, pages 155-162.
Crossref
Crossref
Shu-Feng Zhou. 2010. Supportive Cancer Care with Chinese Medicine. Supportive Cancer Care with Chinese Medicine
293
340
.
Jean-Pierre Gillet & Michael M. Gottesman. 2010. Multi-Drug Resistance in Cancer. Multi-Drug Resistance in Cancer
47
76
.
Tristan M. Sissung & William D. Figg. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer
163
177
.
Henriette E. Meyer zu Schwabedissen & Richard B. Kim. (2009) Hepatic OATP1B Transporters and Nuclear Receptors PXR and CAR: Interplay, Regulation of Drug Disposition Genes, and Single Nucleotide Polymorphisms. Molecular Pharmaceutics 6:6, pages 1644-1661.
Crossref
Crossref
Connie Oshiro, Sharon Marsh, Howard McLeod, Michelle Whirl Carrillo, Teri Klein & Russ Altman. (2009) Taxane pathway. Pharmacogenetics and Genomics 19:12, pages 979-983.
Crossref
Crossref
Julia B. Hennermann, Sylvia Roloff, Jutta Gellermann, Annette Grüters & Jeannette Klein. (2009) False‐positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency. Journal of Inherited Metabolic Disease 32:S1, pages 355-359.
Crossref
Crossref
Chunshan Gui & Bruno Hagenbuch. (2009) Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1. Protein Science 18:11, pages 2298-2306.
Crossref
Crossref
Omar Janneh, Tariq Anwar, Christof Jungbauer, Stefan Kopp, Saye H Khoo, David J Back & Peter Chiba. (2008) P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. Antiviral Therapy 14:7, pages 965-974.
Crossref
Crossref
Akihiro Tanimoto. (2009) Gadoxetic acid (Gd-EOB-DTPA) in contrast-enhanced MRI for the diagnosis of hepatocellular carcinoma. Imaging in Medicine 1:1, pages 33-46.
Crossref
Crossref
A Kalliokoski & M Niemi. (2009) Impact of OATP transporters on pharmacokinetics. British Journal of Pharmacology 158:3, pages 693-705.
Crossref
Crossref
Takahisa Furuta. (2009) Pharmacogenomics in chemotherapy for GI tract cancer. Journal of Gastroenterology 44:10, pages 1016-1025.
Crossref
Crossref
Masato Narita, Etsuro Hatano, Shigeki Arizono, Aya Miyagawa-Hayashino, Hiroyoshi Isoda, Koji Kitamura, Kojiro Taura, Kentaro Yasuchika, Takashi Nitta, Iwao Ikai & Shinji Uemoto. (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. Journal of Gastroenterology 44:7, pages 793-798.
Crossref
Crossref
Mayuko Miyagawa, Kazuya Maeda, Akinori Aoyama & Yuichi Sugiyama. (2009) The Eighth and Ninth Transmembrane Domains in Organic Anion Transporting Polypeptide 1B1 Affect the Transport Kinetics of Estrone-3-Sulfate and Estradiol-17β-D-glucuronide. Journal of Pharmacology and Experimental Therapeutics 329:2, pages 551-557.
Crossref
Crossref
SD Baker, J Verweij, GA Cusatis, RH van Schaik, S Marsh, SJ Orwick, RM Franke, S Hu, EG Schuetz, V Lamba, WA Messersmith, AC Wolff, MA Carducci & A Sparreboom. (2008) Pharmacogenetic Pathway Analysis of Docetaxel Elimination. Clinical Pharmacology & Therapeutics 85:2, pages 155-163.
Crossref
Crossref
Mikihisa Takano, Yoshifumi Otani, Minori Tanda, Masashi Kawami, Junya Nagai & Ryoko Yumoto. (2009) Paclitaxel-resistance Conferred by Altered Expression of Efflux and Influx Transporters for Paclitaxel in the Human Hepatoma Cell Line, HepG2. Drug Metabolism and Pharmacokinetics 24:5, pages 418-427.
Crossref
Crossref
Sing-Huang Tan, Soo-Chin Lee, Boon-Cher Goh & John Wong. (2008) Pharmacogenetics in Breast Cancer Therapy. Clinical Cancer Research 14:24, pages 8027-8041.
Crossref
Crossref
Kazuya Maeda, Hiroshi Suzuki & Yuichi Sugiyama. 2008. Drug Bioavailability. Drug Bioavailability
277
332
.
Chunshan Gui & Bruno Hagenbuch. (2008) Amino Acid Residues in Transmembrane Domain 10 of Organic Anion Transporting Polypeptide 1B3 Are Critical for Cholecystokinin Octapeptide Transport. Biochemistry 47:35, pages 9090-9097.
Crossref
Crossref
Ryan M. Franke & Alex Sparreboom. (2008) Inhibition of Imatinib Transport by Uremic Toxins During Renal Failure. Journal of Clinical Oncology 26:25, pages 4226-4227.
Crossref
Crossref
Kazuma Kiyotani, Taisei Mushiroda, Michiaki Kubo, Hitoshi Zembutsu, Yuichi Sugiyama & Yusuke Nakamura. (2008) Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer Science 99:5, pages 967-972.
Crossref
Crossref
Chunshan Gui, Yi Miao, Lucas Thompson, Bret Wahlgren, Melissa Mock, Bruno Stieger & Bruno Hagenbuch. (2008) Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. European Journal of Pharmacology 584:1, pages 57-65.
Crossref
Crossref
Zyting Chu, Jen-Shi Chen, Chi-Ting Liau, Hung-Ming Wang, Yung-Chang Lin, Muh-Hwa Yang, Po-Min Chen, Erin R. Gardner, William D. Figg & Alex Sparreboom. (2008) Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients. Anti-Cancer Drugs 19:3, pages 275-281.
Crossref
Crossref
Hiroaki Yamaguchi, Minako Kobayashi, Masahiro Okada, Toshiko Takeuchi, Michiaki Unno, Takaaki Abe, Junichi Goto, Takanori Hishinuma & Nariyasu Mano. (2008) Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes. Cancer Letters 260:1-2, pages 163-169.
Crossref
Crossref
Tristan M. Sissung, Erin R. Gardner, Rui Gao & William D. Figg. 2008. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
41
62
.
Stephan Mielke. (2007) Individualized pharmacotherapy with paclitaxel. Current Opinion in Oncology 19:6, pages 586-589.
Crossref
Crossref
Mitsuhisa Muto, Tohru Onogawa, Takashi Suzuki, Takanori Ishida, Toshiki Rikiyama, Yu Katayose, Noriaki Ohuchi, Hironobu Sasano, Takaaki Abe & Michiaki Unno. (2007) Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Science 98:10, pages 1570-1576.
Crossref
Crossref
Anne T. Nies. (2007) The role of membrane transporters in drug delivery to brain tumors. Cancer Letters 254:1, pages 11-29.
Crossref
Crossref
N F Smith, S Marsh, T J Scott-Horton, A Hamada, S Mielke, K Mross, W D Figg, J Verweij, H L McLeod & A Sparreboom. (2007) Variants in the SLCO1B3 Gene: Interethnic Distribution and Association with Paclitaxel Pharmacokinetics. Clinical Pharmacology & Therapeutics 81:1, pages 76-82.
Crossref
Crossref
T. Musumeci, C.A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, R. Pignatello & G. Puglisi. (2006) PLA/PLGA nanoparticles for sustained release of docetaxel. International Journal of Pharmaceutics 325:1-2, pages 172-179.
Crossref
Crossref
Katrin Letschert, Heinz Faulstich, Daniela Keller & Dietrich Keppler. (2006) Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes. Toxicological Sciences 91:1, pages 140-149.
Crossref
Crossref
Alex Sparreboom & William D. Figg. (2006) Identifying Sources of Interindividual Pharmacokinetic Variability with Population Modeling. Clinical Cancer Research 12:7, pages 1951-1953.
Crossref
Crossref
Sharon Marsh. (2006) Taxane pharmacogenetics. Personalized Medicine 3:1, pages 33-43.
Crossref
Crossref
Alex Sparreboom, Sharyn D. Baker & Jaap Verweij. (2005) Paclitaxel Repackaged in an Albumin-Stabilized Nanoparticle: Handy or Just a Dandy?. Journal of Clinical Oncology 23:31, pages 7765-7767.
Crossref
Crossref